IMMUNO MYCOLOGIES INC

Immuno Mycologies Inc. specializes in the manufacturing of in-vitro diagnostic reagents and the development of specialized immunoassays for fungal and infectious disease detection. The company’s core technical expertise lies in complement fixation testing, antibody-based reagent kits, and enzyme immunoassay (EIA) platforms, with demonstrated proficiency in detecting pathogens such as Coccidioides and Talaromyces marneffei. Their work involves the design, validation, and production of clinically validated diagnostic controls and reagents used in clinical laboratories, particularly for immunocompromised patient populations. A key differentiator is their focus on rare fungal antigens and the development of rapid, in-house diagnostic solutions that improve turnaround time and accessibility in federal healthcare settings. The company maintains a strong, recurring relationship with the Department of Veterans Affairs, consistently supplying diagnostic test kits and reagents for mycological and serological screening. These contracts reflect a trusted, operational partnership centered on sustaining diagnostic capacity for veterans at risk for endemic fungal infections. A single award from the Department of Health and Human Services highlights their capability in translational research, specifically in validating novel EIA assays for emerging fungal pathogens, indicating a dual role as both manufacturer and research collaborator. Immuno Mycologies operates primarily within NAICS 325413, focusing on the production of diagnostic substances for clinical microbiology and immunology labs. Their market positioning is niche yet critical, serving the specialized needs of infectious disease diagnostics in immunology and mycology, particularly for underdiagnosed fungal infections in vulnerable populations. They are not broadly diversified across biotech sectors but are deeply embedded in the diagnostic reagent supply chain for federal health systems. As a small business structured as a 2L entity based in Norman, Oklahoma, Immunology Mycologies Inc. has no federal certifications on record. Their geographic presence is centralized, with operations tailored to meet the precise, high-integrity requirements of government health agencies, positioning them as a reliable supplier of specialized diagnostic tools rather than a broad-spectrum biotech firm.